(166) demonstrated that HBx increased pancreatic cancer risk by modulating the PI3K–Akt signaling pathway, with elevated expression of human epidermal growth factor receptor 4 (ErbB4) and TGF-α in parallel with HBx protein expression (Figure 4B). Here, AKT1 is linked to pancreatic neoplasm.